Cargando…

Comparison and identification of early clinical, biological and echocardiographic prognostic markers in cardiac amyloidosis

Detalles Bibliográficos
Autores principales:	Damy, Thibaud, Jaccard, Arnaud, Guellich, Aziz, Lavergne, David, Jean, François Deux, Dupuis, Jehan, Frenkel, Valérie, Mohty, Dania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642085/ http://dx.doi.org/10.1186/1750-1172-10-S1-P60

Ejemplares similares

Left ventricular and atrial function in systemic light chains amyloidosis: an echocardiography and cardiac magnetic resonance comparison
por: Mohty, Dania, et al.
Publicado: (2015)

Posterior longitudinal strain by speckle tracking echocardiography, marker of cardiac amyloidosis?
por: Ternacle, Julien, et al.
Publicado: (2015)

Echocardiographic Patterns of Left Ventricular Diastolic Function in Cardiac Amyloidosis: An Updated Evaluation
por: Oghina, Silvia, et al.
Publicado: (2021)

Transthyretin cardiac amyloidosis in Saudi Arabia and the Middle East: insights, projected prevalence and practical applications
por: Mohty, Dania, et al.
Publicado: (2023)

Usefulness of 99mTc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis
por: Galat, Arnault, et al.
Publicado: (2015)

Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis
por: Ridouani, Fourat, et al.
Publicado: (2018)

Causes and consequences of cardiac fibrosis in patients referred for surgical aortic valve replacement
por: Galat, Arnault, et al.
Publicado: (2019)

Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis
por: Abroud, Hajer, et al.
Publicado: (2022)

History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis
por: Kharoubi, Mounira, et al.
Publicado: (2021)

AL Amyloidosis
por: Desport, Estelle, et al.
Publicado: (2012)

Development and Validation of a New Tool to Assess Burden of Dietary Sodium Restriction in Patients with Chronic Heart Failure: The BIRD Questionnaire
por: Audureau, Etienne, et al.
Publicado: (2018)

Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis – Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)
por: Kristen, Arnt V., et al.
Publicado: (2017)

Prevalence and determinants of iron deficiency in cardiac amyloidosis
por: Jobbé‐Duval, Antoine, et al.
Publicado: (2022)

Echocardiographic markers of cardiac amyloidosis in patients with heart failure and left ventricular hypertrophy
por: Polo, Jorge Melero, et al.
Publicado: (2023)

Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement
por: Bézard, Mélanie, et al.
Publicado: (2021)

Pulmonary hemodynamic responses to inhaled NO in chronic heart failure depend on PDE5 G(-1142)T polymorphism
por: Damy, Thibaud, et al.
Publicado: (2011)

Valve disease in cardiac amyloidosis: an echocardiographic score
por: Aimo, Alberto, et al.
Publicado: (2023)

Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature
por: Adam, Robert Daniel, et al.
Publicado: (2021)

Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy
por: Aouate, David, et al.
Publicado: (2020)

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Damy, Thibaud, et al.
Publicado: (2019)

Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy
por: Damy, Thibaud, et al.
Publicado: (2016)

Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis
por: Fischer, Kilian, et al.
Publicado: (2021)

Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study
por: Nicol, Martin, et al.
Publicado: (2023)

Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis
por: Chacko, Liza, et al.
Publicado: (2022)

Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild‐type cardiac amyloidosis
por: Kharoubi, Mounira, et al.
Publicado: (2020)

Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg
por: Broussier, Amaury, et al.
Publicado: (2021)

DISCOVERY: a study examining the prevalence of transthyretin mutations in subjects suspected of having cardiac amyloidosis
por: Akinboboye, Olakunle, et al.
Publicado: (2015)

Echocardiographic and clinical predictors of cardiac amyloidosis: limitations of apical sparing
por: Kyrouac, Douglas, et al.
Publicado: (2021)

A novel echocardiographic risk score for light-chain amyloidosis
por: Geenty, Paul, et al.
Publicado: (2023)

Established and candidate transthyretin amyloidosis variants identified in the Saudi population by data mining
por: Abouelhoda, Mohamed, et al.
Publicado: (2021)

Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy
por: Quarta, C. Cristina, et al.
Publicado: (2022)

Coexistence of aortic valve stenosis and cardiac amyloidosis: echocardiographic and clinical significance
por: Peskó, Gergely, et al.
Publicado: (2019)

Case report regarding the evolution of electrocardiographic and echocardiographic features in cardiac amyloidosis
por: Vervaat, Fabienne E, et al.
Publicado: (2021)

British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of cardiac amyloidosis
por: Moody, William E., et al.
Publicado: (2023)

Cardiac Findings and Events Observed in an Open-Label Clinical Trial of Tafamidis in Patients with non-Val30Met and non-Val122Ile Hereditary Transthyretin Amyloidosis
por: Damy, Thibaud, et al.
Publicado: (2015)

Electrical cardioversion of atrial arrhythmias with cardiac amyloidosis in the era of direct oral anticogulants
por: Touboul, Olivier, et al.
Publicado: (2022)

Patients with cardiac amyloidosis are at a greater risk of mortality and hospital readmission after acute heart failure
por: Berthelot, Emmanuelle, et al.
Publicado: (2023)

Cardiac amyloidosis: A survey of current awareness, diagnostic modalities, treatment practices, and clinical challenges among cardiologists in selected Middle Eastern countries
por: Mohty, Dania, et al.
Publicado: (2023)

Echocardiographic diagnosis of cardiac amyloidosis: Does the masquerader require only a "cherry on top"?
por: Kiotsekoglou, Anatoli, et al.
Publicado: (2020)

Echocardiographic findings focused on the inferior vena cava partly aid the diagnosis of cardiac amyloidosis
por: Fujiyoshi, Kazuhiro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_to22m951hje4dd3dr7leqear8l